The Australian Centre for Hepatitis Virology (ACHV) is an incorporated body of biomedical scientists throughout Australia with the common interest of promoting and disseminating research into all aspects of the hepatitis and related viruses.
ACHV Workshops
29 November - 2 December 2023
The 18th ACH4 annual scientific workshop was held in conjunction [...]
25-27th May 2022
The 17th ACH2 annual scientific workshop was held at the [...]
2 - 4 June 2021
The 16th ACH2 annual scientific workshop was held at Peppers [...]
Tweets
In early HCV infection, CD8 T cells without neutralizing antibodies drive viral escape, lowering fitness. Later, compensatory mutations restore fitness, enabling chronic infection. Early combined T & B cell responses are key for clearance. #HCV #virology
We hope you've registered for #GHS2025 in Los Angeles, March 18-21. @globalhep Director John Ward will co-chair! More info here: https://buff.ly/4fGdmMs
A new study reveals the 3-antigen HBV vaccine (PreHevbrio®) generates superior immunity than single-antigen vaccines. Enhanced T-cell responses to PreS antigens are key to its success. Promising for improving HBV vaccination outcomes. #HBV #Vaccines https://www.sciencedirect.com/science/article/pii/S0264410X24011952
Agent-based modeling bridges the gap between controlled human infection models and real-world testing for HCV vaccines. Simulations of trials with PWID show robust design but highlight the need for ≥50% vaccine efficacy to ensure success. #HCV #Vaccines